Beijing: One of the leading vaccines in the world made by China’s Sinopharm has reportedly been administered to lakhs of people.
The vaccine comes in two-doses and it is reported that none of the recipients developed an adverse reaction or infection.
The vaccine has been administered under an emergency-use programme and is being tested on frontline workers. Pregnant and breast-feeding women are not being given the vaccine.
The state-run company has invested over 2 billion USD for the vaccine and is currently carrying Phase 3 testing in the Middle-East and South Africa, apart from China. The vaccine is based on an inactive coronavirus. The Oxford vaccine, which recently hit a roadblock after a volunteer develops an unexplained illness, is based on Chimpanzee adenovirus.
Sinopharm’s vaccine is expected to hit the market by the end of the year if everything goes right.
Bhubaneswar: After a two-day closure due to heavy rainfall, Similipal National Park located in Odisha’s…
Bhubaneswar: The Annual Founder’s Day of SAI International Residential School (SIRS) was celebrated in style,…
Balasore: Tension prevailed at Kamarda Bazar in Odisha’s Balasore district during a crackdown by excise…
New Delhi: A private plane crashed in Gramado, a popular mountain resort town in Brazil,…
Keonjhar: Desecration of a Hanuman idol in Barbil area of Odisha's Keonjhar district triggered stiff…
Mumbai: The much-delayed schedule for the 2025 Champions Trophy has been finalised. As per the…
This website uses cookies.